. . . .Merck & Co., Inc.
at Citi Global Healthcare Conference
Tuesday, March 1, 2011
8:00 a.m. ET
New York, NY. . . .
We’ll liveblog any high- (or low-)lights. Expect easy questions, given that Citi received a lead role in, and large fees from Merck’s last $2 billion debt underwriting — in December 2010. Also recall that Citi has a $34 target on Merck. Will there be any announcement on the J&J arbitration? Wild.